Patient Present Sever Sign Segment Upper Develop Differ Studi Syndrom

Patient Present Sever Sign Segment Upper Develop Differ Studi Syndrom

Diseases 1: Acute Disease (544) 2: Pulmonary Embolism (39) acut aml chronic clinic complic diseas group activ associ case clinic diagnos leukaemia leukemia manifest mds mild myeloid diagnosi diagnost factor incid men patient present sever sign mortal platelet preval symptom syndrom transplant patient protein rate risk studi women year 3: Somnambulism (1) 4: Night Terrors (2) adult conserv data depress disord care complex cost decreas famili elderli enhanc increas literatur mean old older peopl potenti releas stimul studi form format increas inform year young younger manag medic member particip person physician potenti practic report stimul target 5: Dog Diseases (124) 6: Myelodysplastic Syndromes (208) asymmetri canin cat deform digit distal acut aml bcr-abl blast chronic cml flt3 hematolog imatinib leukaemia leukem dog foot hand later left leg limb proxim rabbit radial report right leukemia lymphoblast marrow mds myelodysplast myeloid patient relaps segment upper syndrom 7: Nervous System Malformations (25) 8: Fetal Diseases (100) analysi associ brain cell control birth deliveri fetal fetu fetus develop differ gestat infant matern mother express featur gene neonat newborn placent placenta pregnanc pregnant prenat human mechan mice preterm twin week women mutat normal number requir studi syndrom tissu 1 9: Kidney Diseases (109) 10: Muscular Dystrophies (65) associ chronic clear creatinin develop dialysi diseas contract dmd dystrophi dystrophin exercis fiber gene failur famili gene glomerular kidnei muscl muscular mutat myoblast myopathi perform role skelet smc smooth strength nephropathi patient progress rcc renal train weak studi tubul tubular 11: Carcinoma, Small Cell (135) 12: Lung Neoplasms (1286) a549 adenocarcinoma alveolar associ cancer a549 adenocarcinoma alveolar bronchial cancer carcinoma case cell compar control lung cell compar includ lung non-smal non-smal non-small-cel nsclc patient pulmonari size non-small-cel nsclc observ patient pulmonari respect small studi tumor sclc small studi tumor 13: Chromosome Aberrations (688) 14: Asthma (240) aberr abnorm analysi arm breakpoint case airwai allerg allergen allergi chromosom cytogenet asthma cftr chronic conduct delet duplic gene genet karyotyp loss molecular mosaic rearrang region transloc trisomi copd cystic diseas eosinophil fibrosi ige obstruct pulmonari respiratori sever studi ventil 15: Bronchial Hyperreactivity (21) 16: Genetic Predisposition to Disease airwai allerg allergen associ (2191) allel associ diseas factor famili frequenc gene asthma cftr control cystic genet genotyp haplotyp diseas eosinophil fibrosi ige mice individu molecular mutat obstruct pulmonari respiratori polymorph popul risk snp suscept variant variat sever studi test ventil 2 17: Spherocytosis, Hereditary (9) 18: Hemophilia B (24) adult analysi caus cell child childhood analysi assai associ bleed detect children clinic defici domin factor folat genet group increas famili genet mutat new parent pediatr phenotyp level mthfr plasma popul treatment year patient platelet risk sensit studi thrombosi venou 19: Cat Diseases (53) 20: Lymphoma (224) canin cat clinic deform diagnosi diagnost b-cell case cell clinic cll diffus hodgkin human immunoglobulin larg leukemia lymphocyt lymphoid differ distal dog hand isol later left limb proxim rabbit report right lymphoma malign nhl non-hodgkin patient rituximab t-cell segment studi 21: Sphingolipidoses (1) 22: HIV Infections (534) activ basi biosynthesi catalyt conform crystal aids antiretrovir env envelop gag herp hiv enzym experi gener involv mechan molecular organ possibl process hiv-1 hsv hsv-1 human structur substrat underli immunodefici infect opn replic understand understood revers simplex viral viru virus 23: Acquired Immunodeficiency Syn- 24: Arenaviridae Infections (3) drome (123) adult care caus compar aids antiretrovir differ env envelop gag herp control frequenc health high hiv hiv-1 hsv hsv-1 human infect lead level low manag medic resist rna target viral viru year immunodefici infect new replic simplex viral viru virus 3 25: Hemophilia A (85) 26: Tooth Abnormalities (38) abnorm anomali case cleft clinic congenit defect associ bleed coagul factor fibrinogen dental develop facial famili increas lip palat folat folic homocystein leiden mthfr patient patient report respons sever plasma platelet reductas risk studi thrombin thrombosi venou vitamin syndrom teeth 27: Voice Disorders (4) 28: Tooth Loss (9) case data differ diseas follow gener incid loss caus data estim famili genet mean measur method multipl patient persist predict state group higher incid life men studi subject valu variabl mortal patient popul preval rate select studi subject women year 29: Mandibular Fractures (3) 30: Persistent Vegetative State (44) adapt case children complic condit argu articl concern conflict consent debat degre hospit patient period discuss ethic inform issu medic moral paper patient practic public question point region report select sequenc surgeri surgic temperatur research scientif social time tumour year 31: Osteosarcoma (109) 32: Syndrome (677) abnorm anomali associ case caus clinic congenit activ analysi associ bone case cell children express gene group human kit line defect disord domin famili featur inherit malform patient protein respons sarcoma stromal studi tumor mutat patient report retard sever syndrom 4 33: Hepatitis C, Chronic (100) 34: Leukemia, Myelocytic, Acute (184) aim bile biliari chronic cirrhosi duct fibrosi hbv hcv acut aml bcr-abl blast children chronic cml group imatinib leukaemia leukem hepat hepatocyt hepatoma infect liver methods patient replic viral viru virus leukemia lymphoblast marrow mds myelodysplast myeloid patient relaps syndrom 35: Intestinal Neoplasms (52) 36: Stomach Neoplasms (475) analysi cancer cell chronic develop adenocarcinoma aim associ cancer erad examin diseas express gene human increas gastric gastrointestin helicobact intestin mice mous mutat number infect intestin methods mucin mucosa pylori relat respect stomach studi ulcer patient rate tissu tumor tumour 37: Adenocarcinoma (861) 38: Esophageal Neoplasms (202) adenocarcinoma analysi cancer associ carcinoma common carcinoma cell colon colorect express gastric gene esophag frequent includ investig italian mesothelioma observ possibl lesion lung pancreat patient prostat stain studi occur occurr probabl relat report studi transmiss surviv tissu tumor transmit tumor 39: Carcinoma, Signet Ring Cell (17) 40: Rhinitis (12) cancer case cell chang compar decreas assai asthma compar control delet develop express gastric gene correl detect effect fibrosi group increas phenotyp gener genet identifi patient pylori rate report studi tissu tumor requir screen sensit signific studi subject treatment year 5 41: Corneal Diseases (42) 42: Scleritis (3) aberr ablat case conclusions cornea biolog care caus conclusions corneal correct corneal correct develop diseas health hospit lead evalu examin mean measur methods method methods patient myopia ocular patient perform refract procedur protocol servic studi system techniqu studi thick visual 43: Eye Neoplasms (40) 44: Neoplasms, Multiple Primary (84) analysi case cell clinic diagnosi associ cancer case cell describ diagnos featur group lesion method patient popul diagnosi featur literatur man multipl patient phenotyp present rare report reveal risk tumor woman rate role specimen stain studi tissu treatment tumor tumour 45: Endophthalmitis (11) 46: Melanoma (541) analysi case cataract clinic compar dai differ demonstr elong immun melanocyt melanoma microrna mirna nevi pol polymeras requir respons diseas glaucoma group higher ribozym rna rnase small transcript tumor uveal implant increas infect len measur popul vitro rate role studi 47: Adenocarcinoma, Sebaceous (3) 48: Sebaceous Gland Neoplasms (6) alpha approach carcinoma chines compar carcinoma case clinic express famili concentr control differ form format identifi individu member method frequenc method plai express normal patient phenotyp report receptor role signific strategi studi subtyp screen skin techniqu tissu tumor techniqu tumor 6 49: Glaucoma, Angle-Closure (18) 50: Glaucoma, Neovascular (6) activ anterior associ cataract adult case clinic conclusions differ diseas estim examin chamber conclusions disc examin famili implant method methods patient glaucoma implant includ pattern primari retin studi target techniqu visual year intraocular iop len methods perform studi surgeri visual 51: Conjunctival Neoplasms (13) 52: Denys-Drash Syndrome (7) aberr associ conclusions cornea abnorm anomali case chain congenit femal gene corneal correct develop examin high mean health includ individu male mutat patient measur methods ocular patient perform protein studi treatment visual year reaction report risk studi syndrom target tumor 53: Liver Neoplasms (686) 54: Carcinoma, Hepatocellular (509) bile carcinoma case cell chronic carcinogenesi carcinoma case cirrhosi correl express hcc hepat hepatocellular cell chronic correl express gene hcc hepat hepatocellular hepatocyt immunohistochem invas liver hepatocyt invas liver methods patient progress methods progress scc squamou tumor scc squamou tumor 55: Vocal Cord Paralysis (9) 56: Branchioma (5) analysi case correl develop improv absenc case clinic diagnosi event experi featur genet initi intern manag origin patient increas life loss patient perform present presenc present process rare report second qualiti rare report reveal sever signific studi sever surgeri surgic 7 57: Colonic Polyps (35) 58: Genomic Instability (191) analysi associ bac cancer cell

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    406 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us